Related Experiment Video
Updated: Mar 7, 2026
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Update on the Medical Management of Gastrointestinal Behçet's Disease
Giuseppe Lopalco1, Donato Rigante2, Vincenzo Venerito1
1Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Piazza Giulio Cesare 11, 70124 Bari, Italy.
Insights
Behçet's disease gastrointestinal involvement (GIBD) is a severe condition often mistaken for inflammatory bowel disease. This review explores potential pharmacological treatments for GIBD, as standardized therapies are lacking.
Area of Science:
- Gastroenterology
- Rheumatology
- Immunology
Background:
- Behçet's disease (BD) is a multisystemic disorder characterized by oral aphthosis, genital ulcers, and uveitis.
- Gastrointestinal involvement in Behçet's disease (GIBD) is a severe manifestation, often clinically and pathologically resembling inflammatory bowel diseases (IBD).
- Differential diagnosis between GIBD and IBD (Crohn's disease, ulcerative colitis) can be challenging.
Purpose of the Study:
- To review current evidence and clinical experience regarding pharmacological agents for managing GIBD.
- To provide a digest of potential treatments for the gastrointestinal manifestations of Behçet's disease.
Main Methods:
- Literature review of pharmacological agents suggested for GIBD management.
- Analysis of current experience and evidence for treatment efficacy.
Main Results:
- No standardized medical treatments currently exist for GIBD.
- Therapy for GIBD must be individualized based on clinical severity and complications.
- Various pharmacological agents show potential in managing GIBD, as detailed in the literature.
Conclusions:
- Gastrointestinal involvement in Behçet's disease requires tailored therapeutic strategies.
- Further research into standardized and effective pharmacological treatments for GIBD is warranted.
- Early and accurate diagnosis, aided by endoscopic and pathological findings, is crucial for effective management.
Abstract:
Behçet's disease (BD) is a multisystemic disorder of unknown etiology mainly defined by recurrent oral aphthosis, genital ulcers, and chronic relapsing bilateral uveitis, all of which represent the "stigmata" of disease. However, many other organs including the vascular, neurological, musculoskeletal, and gastrointestinal systems can be affected. The gastrointestinal involvement in Behçet's disease (GIBD), along with the neurological and vascular ones, represents the most feared clinical manifestation of BD and shares many symptoms with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. Consequently, the differential diagnosis is often a daunting task, albeit the presence of typical endoscopic and pathologic findings may be a valuable aid to the exact diagnosis. To date, there are no standardized medical treatments for GIBD; therefore therapy should be tailored to the single patient and based on the severity of the clinical features and their complications. This work provides a digest of all current experience and evidence about pharmacological agents suggested by the medical literature as having a potential role for managing the dreadful features of GIBD.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:29Drugs for Treatment of Ulcerative Colitis in IBD